The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 13, 2026
Snapshot (as of Jul 13, 2026): Eli Lilly and Company (LLY) pays a $6.46 annual dividend ($1.73 quarterly), yielding 0.55% at $1185.08/share. Next ex-dividend date 2026-08-14. 52+ consecutive years of dividend growth (Dividend King). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.55%
Annual Dividend: $6.46 per share
Payout Ratio: 22.1%
Ex-Dividend Date: 2026-08-14
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 55
Eli Lilly and Company dividend investors are looking at one of the longest-running payers in the pharmaceutical sector, backed by a portfolio anchored in diabetes care (Trulicity, Jardiance) and oncology. LLY currently yields 0.54%, with a trailing annual dividend rate of $6.46 per share paid quarterly. The next ex-dividend date is August 14, 2026. A beta of 0.517 points to below-average price volatility, which suits investors who prioritize steady dividend growth over high current income.
Eli Lilly and Company pays out 22.1% of earnings as dividends, a payout ratio classified as conservative (below 40%). That low retention of earnings as dividends reflects a company directing the majority of its income back into its business, which includes a broad pipeline spanning diabetes treatments, oncology drugs, and autoimmune therapies. Eli Lilly and Company dividend safety benefits from this wide product base, though pharmaceutical revenue can face pressure from patent expirations and pricing dynamics that the payout ratio alone does not capture.
Eli Lilly and Company dividend history shows a CAGR of 8.3% per year from 2011 to 2025. Per-share payments grew from $1.96 to $6.00 over that period (2026 data is partial and excluded from this calculation). The largest annual increase in the window was 15.4% in 2025, while growth was flat across 2012, 2013, and 2014, when the dividend held at $1.96 per share for three consecutive years.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +15.2% | $3.92 (2022) | $6.00 (2025) |
| 5-Year | +15.2% | $2.96 (2020) | $6.00 (2025) |
| 10-Year | +11.6% | $2.00 (2015) | $6.00 (2025) |
LLY fits growth-and-income investors who want a pharmaceutical company with a long dividend-increase record and are willing to accept a low current yield in exchange for above-average growth. The yield of 0.54% is classified as low (below 2%), and it sits above the 5-year average yield of 0.38%, meaning the current entry point offers slightly more income than the historical norm. As a Dividend King with 52 consecutive years of increases, Eli Lilly and Company brings one of the longest unbroken increase streaks in the market. The trade-off is straightforward: income today is modest, but the 8.3% annual growth rate over 14 years shows what compounding looks like over time.
LLY is a Dividend King — 52 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-08-14 | $1.7300 |
| 2026-05-15 | $1.7300 |
| 2026-02-13 | $1.7300 |
| 2025-11-14 | $1.5000 |
| 2025-08-15 | $1.5000 |
| 2025-05-16 | $1.5000 |
| 2025-02-14 | $1.5000 |
| 2024-11-15 | $1.3000 |
| 2024-08-15 | $1.3000 |
| 2024-05-15 | $1.3000 |
| Year | Total Dividends |
|---|---|
| 2026 | $5.1900 |
| 2025 | $6.0000 |
| 2024 | $5.2000 |
| 2023 | $4.5200 |
| 2022 | $3.9200 |
Project income from LLY with the LLY dividend calculator or track your full portfolio with the dividend tracker.